Addus HomeCare Corporation — Cyborg Score 8/10

Strong
Home Care Services / Healthcare & Social Assistance

Strategic Profile

The company demonstrates consistent revenue growth, strong profitability, and a pristine balance sheet, positioning it for sustained acquisitive growth and operational efficiency. The business model is resilient and defensive against cyclical downturns. Addus generates revenue from federal and state governmental agencies, managed care organizations, commercial insurers and private individuals, reflecting diversified payor relationships and participation in government-funded programs.

Cyborg Score Rationale

In 2025, Addus HomeCare's revenue reached $1.42 billion (23.21% growth) with earnings of $95.91 million (30.32% growth). Ten analysts rate the stock as "Buy" with a 12-month average price target of $136.4, representing 30.84% upside. Strong underlying fundamentals, favorable demographic tailwinds, and strategic M&A activities support sustained growth.

Top Insights

  • Supportive policy trends and strong organic demand for home-based care position the company for sustainable recurring revenue and reduced regulatory risk.
  • Federal and state budget pressures, along with Medicaid dependence, threaten revenue stability and expose the company to unpredictable policy risk.
  • Capital Research Global Investors boosted its holdings by 22.3% in the 4th quarter, now owning 1,469,752 shares worth $157.8M, signaling institutional confidence.
  • The market expects Q4 revenue growth of 25.5% year-over-year, a significant acceleration from 7.5% in the prior year quarter.

Named Competitors

  • Home Health & Personal Care — Home health and hospice services provider
  • Senior Care Services — Comprehensive home health and senior care
  • Independent Home Care — Franchise-based in-home senior care

Recent Developments

  • (Mar 2026) Analyst consensus upgraded to "Moderate Buy" across 11 coverage firms with $134.33 average price target
  • (Feb 2026) Stock price at $104.25 with 4.6% outperformance vs. healthcare peers over prior month
  • (Nov 2025) CEO Dirk Allison participated in UBS Global Healthcare Conference; strong institutional investor positioning

Open the full interactive Addus HomeCare Corporation report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →